Stay updated on Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial
Sign up to get notified when there's something new on the Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial page.

Latest updates to the Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedA new revision entry v3.5.0 was added to the record history, and v3.4.3 was removed.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedA new revision entry (v3.4.3) was added and the previous revision (v3.4.2) was removed from the study record history.SummaryDifference0.1%

- Check52 days agoChange DetectedA new revision entry v3.4.2 was added to the record history, and the entry for v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedVersion v3.4.1 was added and v3.4.0 was removed in the record history. There are no visible changes to the study data or status in this view.SummaryDifference0.1%

- Check81 days agoChange DetectedRecord History now shows a new revision v3.3.4 and the removal of v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check103 days agoChange DetectedAdded Revision: v3.3.3 to the Record History; removed the HHS Vulnerability Disclosure link and Revision: v3.3.2.SummaryDifference0.2%

Stay in the know with updates to Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial page.